Article Text

PDF

O18.6 A method to estimate the national prevalence of hiv-infection among female sex workers in zimbabwe by pooling data from multiplie respondent driven sampling surveys and programme consultations
  1. E Fearon1,
  2. JR Hargreaves1,
  3. C Davey1,
  4. J Dirawo2,
  5. P Mushati2,
  6. FM Cowan2,3
  1. 1Department of Social and Environmental Health Research, London School of Hygiene and Tropical Medicine, London, UK
  2. 2Centre for Sexual Health and HIV/AIDS Research Zimbabwe, Harare, Zimbabwe
  3. 3Department of Infection and Population Health, University College London, London, UK

Abstract

Introduction Respondent driven sampling (RDS) surveys are often used to estimate site-specific HIV-prevalence among female sex workers (FSW). Methods to combine data from multiple sites to estimate national or provincial HIV-prevalence are rarely described.

Methodology Using data from the Zimbabwean national FSW HIV prevention programme, working in 36 priority sites across all provinces, we estimated the average number of visits made by FSW to outreach sexual/reproductive health clinics each month at each site between January 2014–Dec 2014. We treated this variable as a proxy for the relative size of the FSW population at each site. We conducted RDS surveys with HIV testing among 200 FSW in 14 of the 36 sites, purposively selected. We used the RDS-2 analysis approach to estimate HIV prevalence in each of the 14 sites. We then combined data from the 14 sites, weighting each site by the proxy for FSW population size to provide an estimate of the national prevalence of HIV among FSW in Zimbabwe.

Results The HIV prevalence across sites ranged from 43 to 79%. The unweighted mean of the site-specific prevalences was 57.5% (95% CI 51.9–62.8%). The mean number of women visiting each site per month over 2014 ranged from 16 to 87. The weighted women visiting each site per month in 2014 mean of the site-specific HIV prevalences was 58.1% (95% CI 53.8.4–62.2%).

Conclusions HIV prevalence among FSW in Zimbabwe is very high but variable by site. We describe an approach to estimating national HIV prevalence from multiple site-specific surveys. Here, weighting made little difference to a mean approach though this may not always be the case. Several future refinements to the method proposed are possible and will be discussed.

 Disclosure of interest statement The SAPPH-IRe trial is using Truvada donated by Gilead. We have no other relationships with commercial entities to disclose.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.